Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)

NCT02958163 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped lack of recruitment

Conditions

Liver Neoplasms
Hepatocellular Cancer

Interventions

PROCEDURE: Trans-arterial Chemo-Embolization
DRUG: Doxorubicin
RADIATION: Stereotactic Ablative Radiotherapy

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]